The initiative aims to help startups develop, test, and validate digital health tools and AI-based solutions designed to address clinical and operational challenges in healthcare.
Mayo Clinic Platform_Accelerate has announced the selection of 18 national and international healthcare technology startups for its latest cohort, bringing companies developing artificial intelligence (AI)-driven solutions to participate in its 30-week innovation program.
The program provides participating companies with access to expert mentors, advanced technology infrastructure, and millions of de-identified, longitudinal clinical records. The initiative aims to help startups develop, test, and validate digital health tools and AI-based solutions designed to address clinical and operational challenges in healthcare.
“The future of healthcare depends on clinical insight and technology advancing together,” said John Halamka, M.D., president of Mayo Clinic Platform. “Accelerate brings entrepreneurs together with Mayo Clinic clinicians and other leading experts to turn ideas into practical solutions that can improve how care is delivered.”
The newly selected cohort includes startups working across multiple healthcare domains, including patient access, remote monitoring, diagnostics, clinical decision support, surgical technology, and care coordination.
Several companies are focused on AI-based automation and patient engagement tools. For example, 100ms develops AI agents to automate patient access workflows for specialty practices, while SPRYT offers an AI medical receptionist that enables patients to schedule and manage appointments via messaging platforms. NousLogic Telehealth provides a remote monitoring platform designed to track vital signs and medication adherence among elderly patients.
Other startups in the cohort are developing clinical AI solutions. NeoCure is building an AI system to detect eye disease in preterm infants using bedside vital data, while Xcoo supports genomic cancer diagnosis and treatment decisions using AI-based analytics. Curenetics is developing a platform to predict patient responses to cancer immunotherapy by integrating clinical, genomic, and imaging data.
The cohort also includes companies focused on surgical innovation and hospital operations. Precision Imaging, a Tokyo-based startup, is developing AI-powered intraoperative navigation tools for orthopedic procedures, while Hoopcare uses AI to automate preoperative assessments and predict postoperative complications.
Startups addressing chronic disease and population health management are also part of the group. YOBO Health and Canary Applied Intelligence are building platforms to support cardio-renal-metabolic care, while EW2Health uses predictive behavioral analytics to support obesity management.
According to Mayo Clinic, the Accelerate program offers participation through a 30-week immersive track or through longer-term engagement pathways aimed at supporting healthcare technology development and validation.
Stay tuned for more such updates on Digital Health News
Source link
